Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism BTLA blockers(B- and T-lymphocyte attenuator blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Germ Cell and Embryonal Neoplasms | Discovery | - | 10 May 2022 |